About Dymes Pharmachem
Dymes Pharmachem is a company based in Hyderabad (India) founded in 2005. It operates as a B2B. Dymes Pharmachem operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Hyderabad, India
- Employees 1
- SectorsHealthcare
- Website dymespharmachem.com
- Legal Name Dymes Pharmachem Limited
- Date of Incorporation 16 Oct, 1992
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹13.33 Cr
FY 2015 · -17% YoY
- EBITDA₹1.09 Cr
FY 2015 · 8% margin
- Employee Count1
Associated legal entities of Dymes Pharmachem
Dymes Pharmachem is associated with 2 registered companies on The Company Check; the primary company is Dymes Pharmachem Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2015) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Dymes Pharmachem Limited CIN U51909TG1992PLC014888 | Amalgamated | 16 Oct 1992 | Hyderabad, Telangana | ₹13.3 Cr | – | 3 | View details |
| A. R. Life Sciences Private Limited CIN U24232TG2007PTC055235 | Active | 23 Aug 2007 | Hyderabad, Telangana | ₹229 Cr | 308 | 2 | View details |
Board of directors of Dymes Pharmachem Limited (Dymes Pharmachem)
Dymes Pharmachem Limited is the primary company behind Dymes Pharmachem. The boards of the 2 registered companies of Dymes Pharmachem currently have 3 directors; the longest-serving is Kallam Subbareddy, appointed in 2007. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kallam Subbareddy DIN 01710974 | Director | 23 Aug 2007 | 19 yrs 1 mo | A. R. Life Sciences Private Limited, Dymes Pharmachem Limited |
| Kallam Krishna Chaitanya DIN 01711009 | Director | 23 Aug 2007 | 19 yrs 1 mo | A. R. Life Sciences Private Limited, Dymes Pharmachem Limited |
| Shilpi Singh DIN 01985161 | Director | 01 Nov 2014 | 11 yrs 11 mo | Dymes Pharmachem Limited |
Financials of Dymes Pharmachem
Figures of Dymes Pharmachem Limited, the primary company behind Dymes Pharmachem, for FY 2015. Revenue was ₹13.33 Cr (-17% year on year). EBITDA was ₹1.09 Cr (8% margin).
- ₹13.33 CrRevenue · FY 2015 · -17% YoY
- ₹1.09 CrEBITDA · 8% margin
- ₹4.50 CrPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Dymes Pharmachem Limited are on its company page.
Detailed financial statements for Dymes Pharmachem
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Dymes Pharmachem
Dymes Pharmachem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| provepharm.com | 1998 | Marseille, France | $145.93M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| biostar-pharm.com | 2002 | Beijing, China | $135.23M | – | APIs, intermediates, and biochemical reagents are developed and manufactured. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| snapdragonchemistry.com | 2014 | Cambridge, United States | – | 43 | Drug discovery and development service provider | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| hikal.com | 1988 | Mumbai, India | – | 355 | APIs and intermediates are produced via custom synthesis and research. |
Detailed competitors of Dymes Pharmachem
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Dymes Pharmachem
10 companies that operate in the same segment as Dymes Pharmachem (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Dymes Pharmachem
Dymes Pharmachem was founded in 2005.
Dymes Pharmachem is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Dymes Pharmachem has 1 employees.
The primary company behind Dymes Pharmachem, Dymes Pharmachem Limited, reported revenue of ₹13.33 Cr for FY 2015, down 17% year on year.
Dymes Pharmachem, based in Hyderabad, focuses on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and api production. Manufactures active pharmaceutical ingredients and intermediates. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Dymes Pharmachem's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Dymes Pharmachem is associated with 2 legal entities: Dymes Pharmachem Limited, A. R. Life Sciences Private Limited.
The legal entities of Dymes Pharmachem currently have 3 directors, including Kallam Subbareddy, Kallam Krishna Chaitanya, Shilpi Singh.